Skip to main content
. 2021 Feb 24;10:1–27. doi: 10.2147/OV.S268426

Table 4.

Clinical Studies with oHSVs in GBM

oHSV Combination Condition N Phase Status Country References
HSV1716 N/A Recurrent malignant glioma 9 N/A Completed UK [187]
N/A High-grade glioma 12 N/A Completed UK [188]
N/A High-grade glioma 12 N/A Completed UK [186]
Dexamethasone Refractory or recurrent high-grade glioma 2 1 Terminated US NCT02031965
G207 N/A Recurrent malignant glioma 21 1 Completed US [190]
N/A Recurrent Brain Cancer 65 1b/2 Completed US NCT00028158
N/A Recurrent GBM 6 1b Completed US [191]
Radiation Recurrent malignant glioma 9 1 Completed US [101]
Radiation Progressive or recurrent supratentorial brain tumors 12 1 Active, not recruiting US [194]
NCT02457845
Radiation Recurrent or refractory cerebellar brain tumors 15 1 Recruiting US [196]
NCT03911388
Radiation Recurrent high-grade glioma 30 2 Not yet recruiting US NCT04482933
G47∆ N/A Progressive GBM 21 1/2 Completed recruiting Japan UMIN000002661
N/A Residual or recurrent GBM 30 2 Completed recruiting Japan UMIN000015995
M032 N/A Recurrent/progressive GBM 36 1 Recruiting US NCT02062827
rQNestin34.5v.2 Cyclophosphamide Recurrent malignant glioma 108 1 Recruiting US NCT03152318
C134 N/A Recurrent GBM 24 1 Active, not recruiting US NCT03657576

Abbreviations: N, number of participants; N/A, not applicable.